Influenza A/H5 Subtyping, NAA

Nasopharyngeal swab

1 swab

1 swab

Universal or Viral Transport Media (UTM or VTM)

Collect NP swab per standard techniques and immediately place swab in 3 mL of UTM or VTM.

Freeze.

Improper collection; inadequate specimen; improper labeling; specimen leaked in transit; quantity not sufficient for analysis; name discrepancies; specimen exceeding storage requirements; nasal swabs or any other upper respiratory sample other than nasopharyngeal swab in universal or viral transport media; samples submitted in non-approved transport devices

This test detects influenza A / H5 subtype by nucleic acid amplification.
 

This test detects sequences for influenza A and the H5 subtype. Influenza A/H5 is currently very rarely found in humans in the United States. Results from this test must be correlated with the clinical history, epidemiological data and other data available to the clinician evaluating the patient. Viral and bacterial nucleic acids may persist in vivo independent of organism viability. Detection of organism target(s) does not imply that the corresponding organisms are infectious or are the causative agents for clinical symptoms. The detection of viral and bacterial nucleic acid is dependent upon proper specimen collection, handling, transportation, storage and preparation. Failure to observe proper procedures in any one of these steps can lead to incorrect results. There is a risk of false positive or false negative values resulting from improperly collected, transported or handled specimens. 

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.

Nucleic Acid Amplification